Metamorph Medtech Information

FDA clearance is not a sales strategy. It's a permission slip. What comes next is a value analysis committee that doesn't want to meet you, a CFO who kills deals in eleven minutes, and an IT security questionnaire longer than your 510(k). Metamorph is a commercial operating partner for medtech and health AI companies entering the U.S. hospital market. We work in the gap between clearance and repeatable revenue, which is where most of the failure lives and almost none of the advice does. What we do Commercial readiness diagnostics. U.S. market entry and segmentation. Evidence and clinical adoption architecture. Pricing, reimbursement, and CFO-grade economics. Hospital access and buying committee navigation. Sales motion and pilot-to-contract conversion. Commercial team design and hiring. Implementation and onboarding. Customer success, retention, and expansion. Strategic partnerships and alliances. What we don't do QA/RA. Regulatory submissions. Trial biostatistics. We know exactly who does, we've watched them work, and we'll bring them. You don't need eleven vendors. You need one person who knows which eleven, and who's accountable for the seams. Who we work with Early-stage medtech and health AI companies building U.S. commercial infrastructure for the first time. International teams entering a market that does not work like their home market. Founders whose board just asked for a commercial plan and who currently have a list of conferences. Strategy is the easy part. We stay for the hard part.